期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Journal of Cardiology LetPub Score 6.1
50 ratings
Rate
Reputation 7.5 Influence 4.9 Speed 7.0 | ||||||||||||||||
期刊簡稱 | J CARDIOL | ||||||||||||||||
ISSN | 0914-5087 | ||||||||||||||||
E-ISSN | 1876-4738 | ||||||||||||||||
h-index | 39 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.journal-of-cardiology.com/ | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/JJCC | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Japanese College of Cardiology (Nippon-Sinzobyo-Gakkai) | ||||||||||||||||
主題領域 | CARDIAC & CARDIOVASCULAR SYSTEMS | ||||||||||||||||
出版國/地區 | IRELAND | ||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||
創刊年 | 0 | ||||||||||||||||
每年文章數 | 125每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 70.34% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0914-5087%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) 來自Elsevier的數據: Average 6 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: 來自Elsevier的數據: 24% | ||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 35.4 Week(s) | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Journal of Cardiology] 的評論 | 撰寫評論 |
作者: 努力啊大孤云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-20 23:15:42 評論於 It has been a week since I applied, but I have not received a confirmation email or assignment number yet(0) 讚! | 努力啊大孤云 |
作者: 东海元彤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-04 10:55:32 評論於 Is there a layout fee for this?(0) 讚! | 东海元彤 |
作者: 拂柳西华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-08 21:19:26 評論於 About three days(0) 讚! | 拂柳西华 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 17:56:02 評論於 The Pearson correlation coefficient (PCC, or Pearson's r) is a widely used measure of linear correlation(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:19:33 評論於 Additive effect refers to the combined effect of two drugs being equal to the effect of each drug at double the dose when used alone. If the therapeutic effect obtained by combining two drugs is greater than the sum of the effectiveness of the two drugs used individually, it is called a synergistic effect. How to determine whether there is a synergistic effect or an additive effect between two drugs? Due to the many factors that can affect efficacy in animal experiments or clinical treatment, unless the result is significantly greater than the sum of the effectiveness of each drug, a synergistic effect can be clearly obtained. Otherwise, it is generally referred to as an enhancement effect(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 12:23:32 評論於 What is synergism? What is additive effect? What is the difference between the two?(0) 讚! | 八坂篷蔚 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 14:29:58 評論於 How do you calculate correlation?(0) 讚! | 八坂篷蔚 |
作者: Hilda Maugham 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-22 11:41:42 評論於 Hello, I am preparing to submit to this magazine, but I keep encountering errors during registration, such as incorrect keyword counts as shown in the image below. Do you know what could be causing this?(0) 讚! | Hilda Maugham |
作者: 昆顿诺埃尔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-03-29 19:12:17 評論於 Review speed: 3.0 | Submission success rate: 50.0 Experience sharing: (one acceptance and one rejection) is still quite easy, but the external review is very serious. It took more than two months for the external review, and after minor revisions, it took another month to be sent for review again. The magazine's layout editor is also very responsible. The magazine is good, and I hope to submit again(0) 讚! | 昆顿诺埃尔 |
作者: Christian Carter 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-03-04 09:09:01 評論於 How did he change the reference format?(0) 讚! | Christian Carter |
作者: 是和平吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-05-25 19:13:12 評論於 Review speed: 1.0 | Submission hit rate: 25.0 Experience sharing: Rejected directly on the second day of submission, maybe because the level is far below the requirements of the magazine hahaha, now the competition is getting tougher and tougher!(0) 讚! | 是和平吖 |
作者: 沛春少女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-04-23 22:19:35 評論於 Submitted but did not receive a confirmation email from the journal. Has anyone encountered this issue before?(0) 讚! | 沛春少女 |
作者: 沛春少女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-04-20 09:51:02 評論於 May I ask if you have received a confirmation email from the magazine after submitting your article? How many days does it usually take to receive a reference number?(0) 讚! | 沛春少女 |
作者: 靖香mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-01-06 22:01:59 評論於 Could you please tell me if there is a layout fee for this magazine? If so, how much is it? Thank you(0) 讚! | 靖香mio |
作者: 东海永军 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-11-22 08:35:16 評論於 Mo Li, how long does the first trial usually take?(0) 讚! | 东海永军 |
作者: 冬冬baby 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-11-11 16:48:52 評論於 Review Speed: 1.0 | Submission Hit Rate: 75.0 Sharing Experience: Feels pretty good, reviewers are nice and provide fair and constructive feedback(0) 讚! | 冬冬baby |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 19:27:11 評論於 Everything can only hope for next year, after all, there is no need to worry as long as the overall trend is upward. Even if it only increases a little bit each year, it will accumulate over time, which is also good(0) 讚! | 凌霄高洁 |
作者: 华清如仪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-10-16 20:02:48 評論於 Do you accept meta?(0) 讚! | 华清如仪 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-06-01 11:53:47 評論於 The tide is rising, and currently the rejection rate is relatively high(0) 讚! | 凌霄高洁 |
作者: 水桥俊峰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-09-05 11:13:22 評論於 Review Speed: 1.0 Experience Sharing: After a major revision, it was still rejected. I feel it was mainly due to carelessness during the editing process(0) 讚! | 水桥俊峰 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-08-27 20:58:50 評論於 Review speed: 6.0 | Submission hit rate: 25.0 Experience sharing: Submitted to Journal for nearly a month(0) 讚! | 凌霄高洁 |
作者: 水桥俊峰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-08-21 14:08:44 評論於 Review speed: 2.0 | Submission acceptance rate: 50.0 Sharing experience: It feels relatively easy. The reviewers provided a lot of comments and we are making revisions accordingly. Currently, two articles are under review, hoping for a good outcome(0) 讚! | 水桥俊峰 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-07-09 12:36:16 評論於 Just received an article, very happy. First review, two months, many opinions from the reviewers, need to revise, need to add. All the revisions have been made, all the additions have been added, and explanations have been provided for what could not be added. After revisions, accepted in two months(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-07-01 10:37:49 評論於 We are ahead by 2 points now. Will we still be slightly ahead next year? There is a lot of hope(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us